Our Services

 
Translating science is a precise art—so is communicating it.
Phase Five Communications- Architects of the Scientific Platform

Architects of the Scientific Platform

 

Phase Five’s approach to building Scientific Platforms remains the industry model for establishing and advancing a product’s value proposition. An organized, central repository of evidence-based messaging, the Scientific Platform guides communications across disciplines; it’s a methodical process that, at Phase Five, is anything but static. Our teams enjoy shaking up how to look at product data, category needs, therapeutic challenges, economic pressures and market dynamics. The result: In a world of generic thinking, Phase Five’s Scientific Platforms are the foundation for the preclinical, clinical and pharmaco-economic stories that drive differentiation and reimbursement.

Phase Five Communications- Architects of the Scientific Platform

An industry leader aligned with the leading minds in medicine

 

Thought leader identification and engagement is one of the things we do best at Phase Five. We have forged and fostered trusted alliances with thousands of physicians, hospitals and associations. The Opinion Leader Registry tool, first introduced by Phase Five, is a high-level database that systematizes touchpoints and formalizes open-ended engagement with top thinkers in virtually every therapeutic category. To further these dialogues Phase Five, in another first, created a dedicated position to serve as a direct line to these healthcare professionals and Key Opinion Leaders, ensuring the relevant, effective and compliant solutions we develop for our clients have the most potent opportunities to reach the people their products serve.

what key opinion leaders have to say

Scientific reach through Phase Five Publications

 

Phase Five Publications is dedicated to seamlessly and compliantly facilitating publications in high-quality, peer-reviewed biomedical journals. Our planning expertise has real-world validation—an 89% acceptance rate with first-choice journals and a 95% rate of overall manuscript acceptance. From concept to final manuscript to tracking submissions, our staff glean insightful feedback from valued investigators and thought leaders. They work directly with authors and regulatory teams to ensure scientifically rigorous submissions, bias-and conflict-free conclusions, and compliance with the International Committee of Medical Journal Editors and GPP3. The result is accurate, effective communications with a proactive publication timeline and management that ensures submission deadlines or goals are met or exceeded.

What the Authors Have to Say

Courage to break norms. Imagination to create new ones

 

Phase Five is a leader in digital platforms and content, delivering constructive, approvable cross-discipline communications in highly targeted surround-sound. Because engaging physicians in contexts that align with their clinical needs, online behaviors and channel preferences is more critical than ever, we continue to push for more effective vehicles and unexpected ways to use new media. To have the reach and continued success with decision makers, we extend beyond our in-house creative and digital studio, tapping into sister companies and leveraging the exclusive partnerships we have formed with OptimizeRx, EveryHealth, IBM Watson and Scroll Motion.

Creating content that opens minds

 
Phase Five is proud of our credible, thought-provoking writing. Whatever the medium—speakers’ bureau presentations, webcasts, scientific visualization, congress booth panels/activities, mobile platforms, sales training, or online content—our multi-talented teams can support the full spectrum of medical education in the commercial, unbranded disease state, or medical affairs arenas. See how we open minds by checking out a few of our publications.
Culture